^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Hodgkin Lymphoma
    Drug:vinblastine (Tubulin inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    09/16/2022
    Excerpt:
    Hodgkin Lymphoma (Age ≥18 years)...Relapsed/Refractory Disease...CHL...Vinblastine